Clinical efficacy of combining fenofibrate with statins in patients with diabetes and hyperlipidemia: a meta-analysis
-
By
-
March 25, 2026
-
1
The meta-analysis evaluated the effectiveness of fenofibrate combined with statins in diabetic patients with hyperlipidemia.
-
2
Eighteen randomized controlled trials involving 2113 participants demonstrated higher efficacy rates for the combination therapy compared to controls.
-
3
Significant improvements were observed in lipid profiles and glycemic control markers, including total cholesterol and fasting plasma glucose.
-
4
Combination therapy with fenofibrate and statins showed superior results over statin monotherapy in managing diabetes-related hyperlipidemia.
-
5
Long-term cardiovascular benefits and potential risks of adverse reactions from combination therapy require further investigation and monitoring.
